Division of Pathological Sciences, Department of Pharmacology and Experimental Therapeutics, Kyoto Pharmaceutical University , Kyoto , Japan.
Department of Veterinary Pharmacology, Graduate School of Agriculture and Life Sciences, The University of Tokyo , Tokyo , Japan.
Am J Physiol Gastrointest Liver Physiol. 2018 Jul 1;315(1):G104-G116. doi: 10.1152/ajpgi.00305.2017. Epub 2018 Mar 22.
In this study, we investigated the role of transient receptor potential melastatin 2 (TRPM2), a nonselective cation channel abundantly expressed in inflammatory cells such as macrophages, in the development of postoperative ileus, a complication of abdominal surgery characterized by gastrointestinal dysmotility. In wild-type mice, we found that intestinal manipulation, a maneuver that elicits symptoms typical of postoperative ileus, delays the transit of fluorescein-labeled dextran, promotes the infiltration of CD68 macrophages, Ly6B.2 neutrophils, and MPO cells into intestinal muscles, boosts expression of IL-1β, IL-6, TNF-α, iNOS, and CXCL2 in intestinal muscles and peritoneal macrophages, enhances phosphorylation of ERK and p38 MAPK in intestinal muscles, and amplifies IL-1β, IL-6, TNF-α, iNOS, and CXCL2 expression in resident and thioglycolate-elicited peritoneal macrophages following exposure to lipopolysaccharide. Remarkably, TRPM2 deficiency completely blocks or diminishes these effects. Indeed, intestinal manipulation appears to activate TRPM2 in resident muscularis macrophages and elicits release of inflammatory cytokines and chemokines, which, in turn, promote infiltration of macrophages and neutrophils into the muscle, ultimately resulting in dysmotility. NEW & NOTEWORTHY Activation of transient receptor potential melastatin 2 (TRPM2) releases inflammatory cytokines and chemokines, which, in turn, promote the infiltration of inflammatory cells and macrophages into intestinal muscles, ultimately resulting in dysmotility. Thus TRPM2 is a promising target in treating dysmotility due to postoperative ileus, a complication of abdominal surgery.
在这项研究中,我们研究了瞬时受体电位 melastatin 2(TRPM2)的作用,TRPM2 是一种非选择性阳离子通道,在炎症细胞(如巨噬细胞)中大量表达,在术后肠梗阻的发展中起作用,术后肠梗阻是一种以胃肠道运动障碍为特征的腹部手术并发症。在野生型小鼠中,我们发现肠道操作,一种引发术后肠梗阻典型症状的操作,会延迟荧光素标记的葡聚糖的转运,促进 CD68 巨噬细胞、Ly6B.2 中性粒细胞和 MPO 细胞渗透到肠道肌肉中,增加肠道肌肉和腹膜巨噬细胞中 IL-1β、IL-6、TNF-α、iNOS 和 CXCL2 的表达,增强肠道肌肉中 ERK 和 p38 MAPK 的磷酸化,并在暴露于脂多糖后增强驻留和巯基乙内酯诱导的腹膜巨噬细胞中 IL-1β、IL-6、TNF-α、iNOS 和 CXCL2 的表达。值得注意的是,TRPM2 缺陷完全阻断或减弱了这些作用。事实上,肠道操作似乎激活了驻留肌层巨噬细胞中的 TRPM2,并引发炎症细胞因子和趋化因子的释放,进而促进巨噬细胞和中性粒细胞渗透到肌肉中,最终导致运动障碍。新的和值得注意的是瞬时受体电位 melastatin 2(TRPM2)的激活释放炎症细胞因子和趋化因子,反过来又促进炎症细胞和巨噬细胞渗透到肠道肌肉中,最终导致运动障碍。因此,TRPM2 是治疗术后肠梗阻引起的运动障碍的一个有前途的靶点,术后肠梗阻是腹部手术的一种并发症。